106 related articles for article (PubMed ID: 15716363)
1. Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population.
Hichiya H; Tanaka-Kagawa T; Soyama A; Jinno H; Koyano S; Katori N; Matsushima E; Uchiyama S; Tokunaga H; Kimura H; Minami N; Katoh M; Sugai K; Goto Y; Tamura T; Yamamoto N; Ohe Y; Kunitoh H; Nokihara H; Yoshida T; Minami H; Saijo N; Ando M; Ozawa S; Saito Y; Sawada J
Drug Metab Dispos; 2005 May; 33(5):630-6. PubMed ID: 15716363
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
Hanioka N; Matsumoto K; Saito Y; Narimatsu S
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
[TBL] [Abstract][Full Text] [Related]
3. Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation.
Rowbotham SE; Boddy AV; Redfern CP; Veal GJ; Daly AK
Drug Metab Dispos; 2010 Aug; 38(8):1261-6. PubMed ID: 20421446
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6α-hydroxylation and amodiaquine N-deethylation.
Tsukada C; Saito T; Maekawa M; Mano N; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Oct; 30(5):366-73. PubMed ID: 26427316
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug-drug interactions.
Gao Y; Liu D; Wang H; Zhu J; Chen C
Xenobiotica; 2010 Jul; 40(7):467-75. PubMed ID: 20459297
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional insights into polymorphic enzymes of cytochrome P450 2C8.
Jiang H; Zhong F; Sun L; Feng W; Huang ZX; Tan X
Amino Acids; 2011 Apr; 40(4):1195-204. PubMed ID: 20848147
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatography analysis of CYP2C8-catalyzed paclitaxel 6alpha-hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():103-7. PubMed ID: 16719379
[TBL] [Abstract][Full Text] [Related]
9. A simple multiplex PCR method for the concurrent detection of three CYP2C8 variants.
Muthiah YD; Lee WL; Teh LK; Ong CE; Salleh MZ; Ismail R
Clin Chim Acta; 2004 Nov; 349(1-2):191-8. PubMed ID: 15469873
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomes.
Ma B; Subramanian R; Schrag ML; Rodrigues AD; Tang C
Drug Metab Dispos; 2004 May; 32(5):473-8. PubMed ID: 15100167
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity.
Kerdpin O; Elliot DJ; Boye SL; Birkett DJ; Yoovathaworn K; Miners JO
Biochemistry; 2004 Jun; 43(24):7834-42. PubMed ID: 15196026
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of CYP2C8 in three Malaysian ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians.
Muthiah YD; Lee WL; Teh LK; Ong CE; Ismail R
J Clin Pharm Ther; 2005 Oct; 30(5):487-90. PubMed ID: 16164496
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of CYP2C8 polymorphisms by high resolution melting analysis.
Chang CC; Lin PC; Lin CH; Yeh KT; Hung HY; Chang JG
Clin Chim Acta; 2012 Jan; 413(1-2):298-302. PubMed ID: 22027337
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians.
DeLozier TC; Lee SC; Coulter SJ; Goh BC; Goldstein JA
J Pharmacol Exp Ther; 2005 Dec; 315(3):1085-90. PubMed ID: 16099926
[TBL] [Abstract][Full Text] [Related]
15. Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro.
Yu L; Shi D; Ma L; Zhou Q; Zeng S
Biopharm Drug Dispos; 2013 Jul; 34(5):278-87. PubMed ID: 23536207
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis.
Kaspera R; Naraharisetti SB; Tamraz B; Sahele T; Cheesman MJ; Kwok PY; Marciante K; Heckbert SR; Psaty BM; Totah RA
Pharmacogenet Genomics; 2010 Oct; 20(10):619-29. PubMed ID: 20739906
[TBL] [Abstract][Full Text] [Related]
17. Utilization of human liver microsomes to explain individual differences in paclitaxel metabolism by CYP2C8 and CYP3A4.
Taniguchi R; Kumai T; Matsumoto N; Watanabe M; Kamio K; Suzuki S; Kobayashi S
J Pharmacol Sci; 2005 Jan; 97(1):83-90. PubMed ID: 15655291
[TBL] [Abstract][Full Text] [Related]
18. Examination of 209 drugs for inhibition of cytochrome P450 2C8.
Walsky RL; Gaman EA; Obach RS
J Clin Pharmacol; 2005 Jan; 45(1):68-78. PubMed ID: 15601807
[TBL] [Abstract][Full Text] [Related]
19. CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes.
Bahadur N; Leathart JB; Mutch E; Steimel-Crespi D; Dunn SA; Gilissen R; Houdt JV; Hendrickx J; Mannens G; Bohets H; Williams FM; Armstrong M; Crespi CL; Daly AK
Biochem Pharmacol; 2002 Dec; 64(11):1579-89. PubMed ID: 12429347
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of CYP2C8 polymorphisms in a North Indian population.
Minhas S; Setia N; Pandita S; Saxena R; Verma IC; Aggarwal S
Genet Mol Res; 2013 Jul; 12(3):2260-6. PubMed ID: 23884769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
